# A Randomized, Double-blind Clinical Investigation to Evaluate the Use of the Relievion™ Device in Treating Migraine.

> **NCT03185559** · NA · TERMINATED · sponsor: **Neurolief Ltd.** · enrollment: 8 (actual)

## Conditions studied

- Migraine

## Interventions

- **DEVICE:** Relievion Device- Treatment Stimulation
- **DEVICE:** Relievion Device- Sham stimulation

## Key facts

- **NCT ID:** NCT03185559
- **Lead sponsor:** Neurolief Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-07-23
- **Primary completion:** 2018-01-09
- **Final completion:** 2018-01-09
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Investigator retierment
- **Last updated:** 2018-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03185559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03185559, "A Randomized, Double-blind Clinical Investigation to Evaluate the Use of the Relievion™ Device in Treating Migraine.". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03185559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*